Ligand Pharmaceuticals Inc LGND:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/13/24 EDT
84.07UNCH (UNCH)
Volume
3,236
Close
84.07UNCH (UNCH)
Volume
101,961
52 week range
49.24 - 94.57
Loading...
  • Open87.34
  • Day High87.53
  • Day Low83.93
  • Prev Close84.07
  • 52 Week High94.57
  • 52 Week High Date02/27/24
  • 52 Week Low49.24
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.51B
  • Shares Out17.96M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change17.71

KEY STATS

  • Open87.34
  • Day High87.53
  • Day Low83.93
  • Prev Close84.07
  • 52 Week High94.57
  • 52 Week High Date02/27/24
  • 52 Week Low49.24
  • 52 Week Low Date10/27/23
  • Market Cap1.51B
  • Shares Out17.96M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change17.71

RATIOS/PROFITABILITY

  • EPS (TTM)5.23
  • P/E (TTM)16.06
  • Fwd P/E (NTM)19.62
  • EBITDA (TTM)34.391M
  • ROE (TTM)13.26%
  • Revenue (TTM)118.313M
  • Gross Margin (TTM)91.82%
  • Net Margin (TTM)81.43%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ligand Pharmaceuticals Inc

 

Profile

MORE
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several United States Food and Drug Administration (FDA)-approved...
John Kozarich Ph.D.
Non-Executive Independent Chairman of the Board
Todd Davis
Chief Executive Officer, Director
Matthew Korenberg
President, Chief Operating Officer
Octavio Espinoza
Chief Financial Officer
Address
555 Heritage Drive, Suite 200
Jupiter, FL
33458
United States

Top Peers

SYMBOLLASTCHG%CHG
RCUS
Arcus Biosciences Inc
17.21UNCHUNCH
PRTA
Prothena Corporation PLC
20.71UNCHUNCH
VIR
Vir Biotechnology Inc
9.77UNCHUNCH
XNCR
Xencor Inc
21.34UNCHUNCH
TARS
Tarsus Pharmaceuticals Inc
38.37UNCHUNCH